HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Nonprofit Pharmaceutical Companies

584.227

-3.532-0.60%

Number of Gainers:12

Number of Losers:19

Number of Flat:3

PE:- -

High:589.700

Open:587.671

Low:576.889

Close:587.759

Volume:68.60M

Turnover:1.27B

Market Cap:357.37B

Float Cap:321.49B

Loading ...

Do Ascletis Pharma’s (SEHK:1672) ASC50 Phase I Results Hint At A Scalable Autoimmune Strategy?

Simply Wall St.

BRIEF-Carsgen Therapeutics Says Yijie Concert Group Purchased 335,000 Shares From November 6 To December 17

Hunan Jiudian Pharmaceutical Co.,Ltd. Accelerates Transition to Innovative Drug R&D with Multi-Pronged Strategy

RemeGen (SEHK:9995): Assessing Valuation After Shanghai Health Care Index Inclusion

Simply Wall St.

20 Provinces Advance Provincial-Level Medical Insurance Pooling, Accelerating Unified National Pharmaceutical Market

CARsgen Therapeutics - Yijie Concert Group Purchased 335,000 Shares From November 6 to December 17

THOMSON REUTERS

Fosun United Health Insurance Withdraws Announcement of 9 Medical Insurance Plans Covering Innovative Drugs

LEE'S PHARM (00950): Senior Business Development Director Michele Dalla Libera Passes Away

Non-Executive Director Guo Huaqing Increases Stake in CARSGEN-B (02171) by 30,000 Shares at HK$14.98 per Share

HK Stock Movement | ACOTEC-B (06669) Rises Nearly 5% in Afternoon Trading as Company Deepens Strategic Collaboration with Boston Scientific

BUZZ-Alphamab Oncology jumps on progress of ovarian cancer drug

Alphamab Oncology - FDA Grants Breakthrough Therapy Designation to Jskn003 for Proc

THOMSON REUTERS

HK Stock Buyback Summary | December 18

CARSGEN-B Spent HK$6.737 Million to Repurchase 466,000 Shares on December 17

BIOSTAR PHARM-B (02563): First Patient Dosed in U.S. Pivotal Clinical Study of Utidelone for Breast Cancer Brain Metastasis

Ascentage Pharma to Present at J.P. Morgan Healthcare Conference

AH Healthcare Assets Stage Afternoon Reversal! Medical ETF Forms Bullish Engulfing Pattern at Low, Signaling Trend Shift? Heavy "Bottom-Fishing" in HK Connect Innovative Pharma, 520880 Hits Record High

Alphamab Oncology's Application for Tumor Drug Accepted by Chinese Regulator

MT Newswires Live

ALPHAMAB-B (09966): JSKN027 IND Application Officially Accepted by CDE

Alphamab Oncology IND Application for JSKN027 Accepted by Chinese Regulator

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/BK1574/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK1574","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1574\",,,,,undefined,":{"symbol":"BK1574","market":"HK","secType":"PLATE","nameCN":"Nonprofit Pharmaceutical Companies","latestPrice":584.22656,"timestamp":1766045292012,"preClose":587.75903,"halted":0,"volume":68600038,"delay":0,"changeRate":-0.00601,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Not Yet Opened","change":-3.532471,"latestTime":"12-18 16:00:00","open":587.6708,"high":589.70044,"low":576.88855,"amount":1269057381,"amplitude":0.021798,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1766107800000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1766021400000,1766030400000],[1766034000000,1766044800000]],"pbRate":4.97274,"peRate":-40.922669,"turnoverRate":0.002491,"increases":10,"decrements":21,"flats":2,"marketCap":357373288832,"floatMarketCap":321494630240},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1574\",,,,,undefined,":{"symbol":"BK1574","high":589.70044,"amplitude":0.021798,"preClose":587.75903,"low":576.88855,"pbRate":"4.97274","latestPrice":584.22656,"volume":68600038,"delay":0,"open":587.6708,"prevYearClose":331.1933,"prevWeekClose":614.11,"prevMonthClose":632.157,"prevQuarterClose":752.859,"fiveDayClose":595.939,"twentyDayClose":610.919,"sixtyDayClose":730.007,"secType":"PLATE","market":"HK","turnoverRate":0.002491,"peRate":-40.922669,"marketCap":357373288832,"floatMarketCap":321494630240,"timestamp":1766045292012,"nameCN":"Nonprofit Pharmaceutical Companies"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK1574\",,,,undefined,":{"bkCode":"BK1574","up":12,"down":19,"flat":3},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK1574\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2592638189","title":"Do Ascletis Pharma’s (SEHK:1672) ASC50 Phase I Results Hint At A Scalable Autoimmune Strategy?","url":"https://stock-news.laohu8.com/highlight/detail?id=2592638189","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592638189?lang=en_us&edition=fundamental","pubTime":"2025-12-19 00:14","pubTimestamp":1766074460,"startTime":"0","endTime":"0","summary":"Ascletis Pharma recently reported positive topline results from a U.S. Phase I trial of ASC50, an in-house oral IL‑17 inhibitor for mild to moderate psoriasis, showing favorable safety, tolerability and target engagement across multiple dose levels with no serious adverse events.\nThe data support convenient once-daily or potentially once-weekly oral dosing and extend patent protection on this new chemical entity through 2043, underscoring a differentiated approach within the autoimmune and...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-1672/ascletis-pharma-shares/news/do-ascletis-pharmas-sehk1672-asc50-phase-i-results-hint-at-a","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-1672/ascletis-pharma-shares/news/do-ascletis-pharmas-sehk1672-asc50-phase-i-results-hint-at-a","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK1515","BK1574","BK1161","01672"],"gpt_icon":0},{"id":"2592790764","title":"BRIEF-Carsgen Therapeutics Says Yijie Concert Group Purchased 335,000 Shares From November 6 To December 17","url":"https://stock-news.laohu8.com/highlight/detail?id=2592790764","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592790764?lang=en_us&edition=fundamental","pubTime":"2025-12-18 23:03","pubTimestamp":1766070225,"startTime":"0","endTime":"0","summary":"BRIEF-Carsgen Therapeutics Says Yijie Concert Group Purchased 335,000 Shares From November 6 To December 17Dec 18  - CARsgen Therapeutics Holdings Ltd 2171.HK:YIJIE CONCERT GROUP PURCHASED 335,000 SHARES FROM NOVEMBER 6 TO DECEMBER 17Further company coverage: 2171.HK ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251218:nFWN3XO0IG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1587","BK1585","02171","BK1574","BK1161"],"gpt_icon":0},{"id":"1189156854","title":"Hunan Jiudian Pharmaceutical Co.,Ltd. Accelerates Transition to Innovative Drug R&D with Multi-Pronged Strategy","url":"https://stock-news.laohu8.com/highlight/detail?id=1189156854","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1189156854?lang=en_us&edition=fundamental","pubTime":"2025-12-18 22:50","pubTimestamp":1766069445,"startTime":"0","endTime":"0","summary":"Hunan Jiudian Pharmaceutical Co.,Ltd. (300705) stated during institutional research that the company is currently undergoing a comprehensive transformation toward innovative drug research and...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["159992","BK1574","300705","BK0239","06978","BK1161"],"gpt_icon":0},{"id":"2592018831","title":"RemeGen (SEHK:9995): Assessing Valuation After Shanghai Health Care Index Inclusion","url":"https://stock-news.laohu8.com/highlight/detail?id=2592018831","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592018831?lang=en_us&edition=fundamental","pubTime":"2025-12-18 22:13","pubTimestamp":1766067199,"startTime":"0","endTime":"0","summary":"RemeGen (SEHK:9995) has just been added to the Shanghai Stock Exchange Health Care Sector Index, a change that puts the biotech directly on the radar of sector trackers and index-linked funds.\nSee our latest analysis for RemeGen.\nThe latest index inclusion comes after a sharp run, with the year to date share price return of 468.99% and a 396.12% one year total shareholder return now giving way to softer short term momentum as traders reassess risk and future growth.\nIf RemeGen’s surge has you...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-9995/remegen-shares/news/remegen-sehk9995-assessing-valuation-after-shanghai-health-c","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-9995/remegen-shares/news/remegen-sehk9995-assessing-valuation-after-shanghai-health-c","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK1574","09995","BK1583","LU1969619763.USD","DCF","BK1161","LU2328871848.SGD"],"gpt_icon":0},{"id":"1190712640","title":"20 Provinces Advance Provincial-Level Medical Insurance Pooling, Accelerating Unified National Pharmaceutical Market","url":"https://stock-news.laohu8.com/highlight/detail?id=1190712640","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1190712640?lang=en_us&edition=fundamental","pubTime":"2025-12-18 21:50","pubTimestamp":1766065840,"startTime":"0","endTime":"0","summary":"During the \"14th Five-Year Plan\" period, China's medical insurance reforms have unleashed sustained institutional dividends—from cross-province direct settlement of medical expenses and...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09939","BK1574","BK1161","BK1515","159938"],"gpt_icon":0},{"id":"2592909739","title":"CARsgen Therapeutics - Yijie Concert Group Purchased 335,000 Shares From November 6 to December 17","url":"https://stock-news.laohu8.com/highlight/detail?id=2592909739","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592909739?lang=en_us&edition=fundamental","pubTime":"2025-12-18 21:42","pubTimestamp":1766065362,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251218:nFWN3XO0IG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1574","BK1587","02171","BK1161","BK1585"],"gpt_icon":0},{"id":"1160431538","title":"Fosun United Health Insurance Withdraws Announcement of 9 Medical Insurance Plans Covering Innovative Drugs","url":"https://stock-news.laohu8.com/highlight/detail?id=1160431538","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1160431538?lang=en_us&edition=fundamental","pubTime":"2025-12-18 21:21","pubTimestamp":1766064115,"startTime":"0","endTime":"0","summary":"Days after the first edition of the \"Commercial Health Insurance Innovative Drug Catalog\" was released, listing 19 innovative drugs for commercial health insurance coverage, the industry eagerly...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1119994496.HKD","LU2347655156.SGD","SG9999017495.SGD","SG9999014898.SGD","LU0048584097.USD","LU1791710400.SGD","IE00B19Z3B42.SGD","LU1670628061.USD","LU1061106388.HKD","600196","LU1037948541.HKD","LU0976567544.SGD","LU2271345857.HKD","BK4581","IE00BZ1G4Q59.USD","IE00BFSS7M15.SGD","IE000M9KFDE8.USD","LU0795875169.SGD","LU0708995401.HKD","IE00B19Z9Z06.USD","LU1066051498.USD","IE00B7KXQ091.USD","LU2023251221.USD","LU2360032135.SGD","LU2461242641.AUD","02196","LU0198837287.USD","LU0211326839.USD","IE0004445239.USD","LU0861579265.USD","LU2236285917.USD","LU0820561909.HKD","LU0545039389.USD","LU2125154935.USD","LU1718418525.SGD","LU1732800096.USD","IE00BWXC8680.SGD","LU2244417387.USD","LU0052756011.USD","LU1548497426.USD","BK4533","IE0004445015.USD","LU2361045086.USD","BK4588","SG9999014914.USD","LU0496365809.HKD","LU0417517546.SGD","LU0109391861.USD","LU0029864427.USD","IE00B19Z8X17.USD","LU0094547139.USD","LU0557290698.USD","LU1854104046.USD","IE0002141913.USD","LU1720051017.SGD","LU1778281490.HKD","LU1064131342.USD","LU2242649171.HKD","SGXZ31699556.SGD","IE00B775H168.HKD","LU1037948897.HKD","LU2362540622.SGD","IE00BFTCPJ56.SGD","LU0053666078.USD","LU0128525929.USD","LU0238689110.USD","LU2028103732.USD","LU2089984988.USD","IE00BJJMRY28.SGD","LU2491050071.SGD","SG9999002224.SGD","LU1267930490.SGD","IE00BKPKM429.USD","LU1983299246.USD","IE00B2B36J28.USD","BK4534","IE0002270589.USD","LU1791710582.SGD","LU1291159041.SGD","LU0882574055.USD","SG9999001176.USD","LU0310800965.SGD","SG9999002232.USD","LU0320765059.SGD","LU0107464264.USD","LU1074936037.SGD","LU0820561818.USD","LU0965509283.SGD","LU2125154778.USD","LU0708994859.HKD","LU2133065610.SGD","LU0211328371.USD","IE00BZ9MQY76.HKD","IE00B19Z9505.USD","IE00BJJMRX11.SGD","IE0005OL40V9.USD","LU1496350502.SGD","LU2552382058.USD","LU0097036916.USD","IE00BN29S564.USD","LU2089284900.SGD","LU0234572021.USD","LU0251132253.USD","SG9999013999.USD","LU1069347547.HKD","IE0009355771.USD","LU0011850046.USD","LU0211327993.USD","LU0211326755.USD","LU0266013472.USD","LU0122379950.USD","LU0553294199.USD","LU1066051225.USD","LU1670627923.USD","LU0203347892.USD","LU0310800379.SGD","LU2211815571.USD","LU1023059063.AUD","IE00BFXG1179.USD","LU0528227936.USD","LU0354030511.USD","LU1267930730.SGD","LU2361044865.SGD","LU1066051811.HKD","LU1674673428.USD","LU2362541513.USD","LU1267930227.SGD","LU0683600562.USD","LU1814569148.SGD","LU1066053197.SGD","LU0661504455.SGD","BK1574","LU0353189680.USD","SG9999018865.SGD","IE00BFSS8Q28.SGD","LU0949170772.SGD","IE00B19Z9P08.USD","LU0689472784.USD","LU0738911758.USD","IE00BKVL7J92.USD","LU1267930573.SGD","LU0965508806.USD","BK1161","LU0256863811.USD","SG9999018857.SGD","LU0058720904.USD","LU1854103824.USD","LU2357305700.SGD","LU1057294990.SGD","SG9999001176.SGD","SG9999014906.USD","SGXZ57979304.SGD","LU1551013342.USD","LU1084165304.USD","LU2552382215.SGD","LU0354030438.USD","LU0077335932.USD","IE00BSNM7G36.USD","LU0820562030.AUD","LU0345770993.USD","LU2087625088.SGD","LU0114720955.EUR","LU0823416689.USD","LU2089283258.USD","BK4585","BK4532","IE00B4JS1V06.HKD","SGXZ81514606.USD","LU0345770308.USD","LU2491049909.HKD","LU0149725797.USD","IE00B19Z8W00.USD","LU0456855351.SGD","LU1674673691.USD","SGXZ51526630.SGD","LU0158827781.USD","LU0310799852.SGD","LU1261432733.SGD","LU2111349929.HKD","LU0342679015.USD","LU2362541273.HKD","LU0289739699.SGD","LU0912757837.SGD","LU1003077747.HKD","LU2264538146.SGD","IE00B1XK9C88.USD","IE00BJJMRZ35.SGD","IE00B19Z3581.USD","LU1934455277.USD","LU0672654240.SGD","IE00B7SZLL34.SGD","LU0787776722.HKD","LU1988902786.USD","IE00BJT1NW94.SGD","LU2112291526.USD","LU1934455194.USD","LU1506573853.SGD","LU0079474960.USD","LU1323610961.USD","LU1934455863.HKD","IE00B894F039.SGD","LU2491050154.USD","LU0965509010.AUD","LU0158827948.USD","LU0353189763.USD","LU0965509101.SGD","LU1914381329.SGD","SG9999014880.SGD","LU2324357040.USD","LU0432979614.USD","LU1153585028.USD","BK4154","LU2552382132.HKD","LU1732799900.SGD","LU1551013425.SGD","LU2279689827.SGD","BK4566","SGXZ99366536.SGD","LU0128525689.USD","IE00B1BXHZ80.USD","IE00B4R5TH58.HKD","LU0795875086.SGD","LU0943347566.SGD","LU0203345920.USD","LU0316494557.USD","LU0187121727.USD","LU1035773651.USD","LU2468319806.SGD","LU1720051108.HKD","LU1989771016.USD","LU2361044949.HKD"],"gpt_icon":0},{"id":"1167570704","title":"LEE'S PHARM (00950): Senior Business Development Director Michele Dalla Libera Passes Away","url":"https://stock-news.laohu8.com/highlight/detail?id=1167570704","media":"Stock News","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1167570704?lang=en_us&edition=fundamental","pubTime":"2025-12-18 17:50","pubTimestamp":1766051420,"startTime":"0","endTime":"0","summary":"LEE'S PHARM (00950) announced that Mr. Michele Dalla Libera, Senior Director of Business Development, passed away on December 15, 2025.","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1583","06622","00950","BK1191","BK1574","BK1587"],"gpt_icon":0},{"id":"1115048263","title":"Non-Executive Director Guo Huaqing Increases Stake in CARSGEN-B (02171) by 30,000 Shares at HK$14.98 per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=1115048263","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1115048263?lang=en_us&edition=fundamental","pubTime":"2025-12-18 15:44","pubTimestamp":1766043859,"startTime":"0","endTime":"0","summary":"Latest data from the Hong Kong Stock Exchange shows that on December 15, Non-Executive Director Guo Huaqing purchased an additional 30,000 shares of CARSGEN-B (02171) at HK$14.98 per share, totaling...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","BK1161","02171","BK1585","BK1587"],"gpt_icon":0},{"id":"1161401285","title":"HK Stock Movement | ACOTEC-B (06669) Rises Nearly 5% in Afternoon Trading as Company Deepens Strategic Collaboration with Boston Scientific","url":"https://stock-news.laohu8.com/highlight/detail?id=1161401285","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1161401285?lang=en_us&edition=fundamental","pubTime":"2025-12-18 14:51","pubTimestamp":1766040696,"startTime":"0","endTime":"0","summary":"ACOTEC-B (06669) surged nearly 5% in afternoon trading, reaching HK$13.17 by the time of writing, with a trading volume of HK$3.04 million. The company has signed a master cooperation agreement and a...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0432979614.USD","BK1100","LU2506951958.HKD","BK4585","LU2506952097.USD","LU0187121727.USD","LU2506951875.HKD","BK4082","BK4504","LU2491050071.SGD","LU0267386448.USD","LU0823417737.USD","SG9999001176.USD","LU0353189680.USD","IE00BFTCPJ56.SGD","LU2491050154.USD","LU2087625088.SGD","LU2362540622.SGD","LU0225283273.USD","LU2265009873.SGD","LU1057294990.SGD","BK4588","LU0114720955.EUR","LU0823416689.USD","LU1989764664.SGD","LU1989764748.USD","LU1023059063.AUD","IE00BJT1NW94.SGD","IE00BJJMRZ35.SGD","LU1983299246.USD","BSX","LU1366192091.USD","LU1291159041.SGD","LU2362541273.HKD","LU0238689110.USD","SGXZ57979304.SGD","LU1989771016.USD","LU2242649171.HKD","LU0011850046.USD","LU2506952170.USD","LU1989772923.USD","LU0251132253.USD","LU2491049909.HKD","LU1720051108.HKD","LU1720051017.SGD","SG9999013999.USD","IE0002141913.USD","LU0048584097.USD","LU0345769128.USD","LU1548497426.USD","IE00B2B36J28.USD","BK1587","LU1718418525.SGD","SG9999001176.SGD","LU2244417387.USD","LU1804176565.USD","LU0528227936.USD","06669","BK4581","LU1061106388.HKD","LU0353189763.USD","LU2112291526.USD","LU0077335932.USD","LU0823417653.USD","LU0122379950.USD","LU0882574055.USD","LU2362541513.USD","LU0266013472.USD","LU1791710582.SGD","LU1791710400.SGD","LU2357305700.SGD","BK1574","LU2324357040.USD","LU1989772840.SGD","IE0009355771.USD","LU1153585028.USD","IE00B4R5TH58.HKD","LU0345769631.USD","LU0950375773.USD"],"gpt_icon":0},{"id":"2592924931","title":"BUZZ-Alphamab Oncology jumps on progress of ovarian cancer drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2592924931","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592924931?lang=en_us&edition=fundamental","pubTime":"2025-12-18 13:37","pubTimestamp":1766036264,"startTime":"0","endTime":"0","summary":"BUZZ-Alphamab Oncology jumps on progress of ovarian cancer drug** Alphamab Oncology 9966.HK rises 7.1% to HK$10.96; set for biggest one-day pct gain since October 2** Stock hits highest since December 15 after three straight sessions of fall** Company says its JSKN003 has been granted breakthrough therapy designation  by U.S. FDA to treat adults with advanced or metastatic platinum-resistant recurrent epithelial ovarian cancer** Adds, \"The grant of this BTD further demonstrates the international regulatory community's confidence in JSKN003's clinical potential and its importance as a novel therapeutic candidate\"** Grant of BTD based on pooled analysis of phase I clinical study in Australia and phase I/II clinical study in China** YTD, stock surges 207.1%  ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251218:nL1N3XO05J:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","09966","BK1161"],"gpt_icon":0},{"id":"2592373929","title":"Alphamab Oncology - FDA Grants Breakthrough Therapy Designation to Jskn003 for Proc","url":"https://stock-news.laohu8.com/highlight/detail?id=2592373929","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592373929?lang=en_us&edition=fundamental","pubTime":"2025-12-18 12:01","pubTimestamp":1766030463,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251218:nFWN3XN1I1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1574","09966","BK1161"],"gpt_icon":0},{"id":"1123079752","title":"HK Stock Buyback Summary | December 18","url":"https://stock-news.laohu8.com/highlight/detail?id=1123079752","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1123079752?lang=en_us&edition=fundamental","pubTime":"2025-12-18 09:12","pubTimestamp":1766020355,"startTime":"0","endTime":"0","summary":"On December 17, 2025, multiple Hong Kong-listed companies conducted share buybacks. Among them, Tencent (00700) recorded the highest buyback amount, repurchasing 1.057 million shares for HKD 636...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1253","LU2399975544.HKD","LU0251144936.SGD","LU0084288322.USD","LU1504937902.USD","SG9999001051.SGD","00909","SG9999001093.SGD","GB00BDT5M118.USD","LU0531971595.HKD","SG9999015945.SGD","LU0828237510.HKD","BK1142","LU0359202008.SGD","SG9999011746.SGD","IE00B0169N27.USD","LU0329678170.USD","BK1587","IE00B5MMRT66.SGD","HK0000252160.HKD","LU0261947096.USD","LU0106259558.USD","BK1556","02273","IE0031814852.USD","BK1575","LU2237443895.HKD","LU0449509016.USD","BK1128","LU0061477393.USD","LU0261950983.USD","02251","LU0192582467.USD","BK1597","LU0070217475.USD","LU0164880469.USD","SG9999004220.SGD","BK1104","IE00B031HY20.USD","IE00BQXX3C00.GBP","LU0106959298.USD","LU2247934214.USD","LU1785774172.SGD","LU0831103253.SGD","LU0572940350.SGD","LU0531970944.HKD","LU0431992006.USD","LU0293314216.USD","LU1568876251.USD","SG9999018857.SGD","LU0819121731.USD","LU2362540622.SGD","02167","LU0327786744.USD","09857","HK0000306701.USD","IE00BQXX3F31.USD","SG9999003461.SGD","LU1211504680.USD","LU1981816686.USD","BK1517","LU1769817096.USD","SG9999015952.SGD","00669","BK1095","00947","LU0541501648.USD","LU1008478684.HKD","LU2460026573.USD","HK0000252152.HKD","LU1794554557.SGD","BK1103","SG9999014898.SGD","LU0516422366.SGD","BK1613","LU0488056044.USD","LU1629966141.USD","LU1769817179.HKD","IE00B031J352.USD","LU0608807946.USD","LU1226288253.USD","LU0210533765.USD","LU1226287875.USD","02319","LU2045819591.USD","BK1607","LU0048388663.USD","LU1152091754.HKD","LU2362541273.HKD","BK1610","LU0049112450.USD","BK1160","BK1608","LU0605514214.HKD","LU1720050803.USD","LU0499858438.USD","LU0541502299.USD","06186","LU0269904917.USD","LU0320764755.SGD","LU1282651048.USD","LU0326950275.SGD","LU0509642566.USD","LU0979878070.USD","LU0651947912.USD","LU0229945570.USD","LU2242644610.SGD","LU0196878994.USD","SG9999013353.USD","00732","00175","LU0577902454.USD","BK1528","LU0051755006.USD","LU1366334651.USD","BK1585","LU2097828557.USD","LU0326948709.USD","BK1149","SGXZ51526630.SGD","BK1515","LU0043850808.USD","LU0886674414.USD","LU1770036033.HKD","LU0611395673.USD","LU1196710195.USD","LU1770034418.SGD","LU2039709279.SGD","LU2279701549.SGD","IE0003851619.USD","LU2097828631.EUR","SG9999018865.SGD","LU0107464264.USD","LU0140636845.USD","LU2251237488.HKD","LU0117844026.USD","LU0594300419.USD","IE00B0169L03.USD","BK1258","02419","LU0348735423.USD","LU2360107325.USD","LU0456827905.SGD","LU1044876610.USD","02517","LU1046422090.SGD","01588","BK1591","LU0878005551.USD","LU0228367735.SGD","LU0370786039.SGD","LU0011963245.USD","LU0441854154.USD","LU0128522744.USD","SG9999000327.SGD","IE00B8L5B284.USD","02598","02018","BK1516","LU0469268626.HKD","BK1237","SG9999002828.SGD","LU2133065610.SGD","01672","IE00BZ08YS42.EUR","SGXZ90724238.SGD","BK1596","LU1282648689.USD","BK1599","BK1508","LU1868837722.USD","LU1282649810.SGD","02171","LU0384037296.USD","LU1868837565.USD","BK1604","BK1583","SG9999001440.SGD","09886","LU1323998911.USD","LU0211977185.USD","LU0675040207.SGD","LU0348766576.USD","BK1504","LU0164872284.USD","01317","IE00B8HQ1Z84.USD","LU0634319403.HKD","LU0029874905.USD","BK1167","SG9999014914.USD","LU1044875133.USD","IE00BYQNZ168.SGD","LU0072913022.USD","LU0345769128.USD","LU2476274308.USD","LU0054450605.USD","02416","LU1481107354.HKD","06078","LU0396098781.USD","LU0828237940.HKD","LU0577902538.SGD","01458","LU0823397103.USD","LU1023057109.AUD","BK1609","01951","LU1883866441.USD","SG9999000418.SGD","09878","LU0651946864.USD","LU1439103000.SGD","LU0797268264.HKD","HK0000500386.USD","LU0210526637.USD","BK1228","81024","EVS.SI","LU1725190679.HKD","09959","LU0203345920.USD","LU0516422952.EUR","LU0577902298.EUR","LU0106252389.USD","LU0251143458.SGD","IE00BZ08YT58.USD","IE0003895053.USD","LU0791590937.USD","03798","LU0259732245.USD","IE0008368742.USD","LU0856984785.SGD","LU0414403682.SGD","LU0737861772.HKD","BK1526","IE0034224299.USD","LU0543330483.HKD","LU0029875118.USD","IE00BGV7N243.SGD","LU0211331839.USD","SGXZ81514606.USD","LU0149534421.HKD","LU0348783233.USD","IE00B0JY6N72.USD","LU1960683339.HKD","LU1718418525.SGD","LU2106854487.HKD","BK1562","LU1282649141.HKD","LU0561508036.HKD","HK0000306685.HKD","LU0608807433.USD","LU1808992512.USD","00345","BK1170","LU0683595622.HKD","LU0348783662.USD","BK1183","BK1521","LU0314109678.HKD","LU0289960550.SGD","IE0032431581.USD","LU2488822045.USD","LU0132412106.USD","LU1251922891.USD","LU0786609619.USD","LU2251237306.USD","09669","LU1807302812.USD","LU1105468828.SGD","LU0039217434.USD","BK1119","LU1734074674.USD","SG9999000459.SGD","LU0862451837.USD","BK1117","LU2087589342.USD","LU0878004406.USD","BK1531","LU0577902611.USD","LU0054237671.USD","LU2051468812.USD","LU0164865239.USD","LU0348814723.USD","LU1733274473.HKD","LU2008162690.USD","LU1226287792.SGD","LU0449515922.USD","LU0588545730.USD","LU0588546209.SGD","LU0882747503.HKD","LU1102505929.USD","LU1814569148.SGD","BK1542","LU1224444064.USD","LU0456846285.SGD","IE00B067MR52.USD","LU0577902371.SGD","LU0348788117.USD","LU1568876335.HKD","LU1242518857.USD","LU1226288097.SGD","SG9999001689.USD","02158","LU0227179875.USD","80175","LU0648948544.HKD","BK1193","BK1505","LU0348784397.USD","LU0593848301.USD","LU0650527681.SGD","BK1617","02369","LU1328277881.USD","IE00BF5LJ272.USD","LU0588545490.SGD","LU2097828805.USD","BK1219","LU1868838027.USD","BK1615","LU0823413660.USD","HK0000320223.HKD","LU0048597586.USD","LU0823397285.USD","LU1235295612.USD","02869","LU2097828714.EUR","LU0865486749.SGD","LU0345776255.USD","BK1506","01024","LU0417516902.SGD","LU0501845795.SGD","LU0348723411.USD","LU0143863198.USD","LU0165289439.USD","LU0543330566.HKD","LU0463099449.HKD","LU0823038988.USD","IE0008369823.USD","LU0244354667.USD","LU1655091459.SGD","BK1155","BK1502","IE0009570106.USD","LU0049853897.USD","SG9999001226.SGD","LU0203347892.USD","03888","06826","LU0127658192.USD","LU0471298777.SGD","BK1619","LU0231483743.USD","LU0072462343.USD","LU1993786604.SGD","LU0417516738.SGD","01919","LU0738912210.USD","LU0502904849.HKD","LU1675838814.USD","LU1282651121.HKD","LU0329678337.USD","LU1226288170.HKD","LU1956131251.USD","LU0972618739.USD","LU1224709979.USD","LU2293587155.HKD","LU1316542783.SGD","LU0823040885.USD","02367","LU1439102457.SGD","LU1951186391.HKD","02299","BK1589","LU2177674079.SGD","00434","06098","LU0117841782.USD","LU3063872942.SGD","SG9999015986.USD","LU1917777945.USD","LU0821914370.USD","LU2778985437.USD","LU0700851271.USD","02038","LU0149721374.USD","LU1152091168.USD","BK1161","LU0890818403.SGD","LU0175139822.USD","LU2097828474.EUR","LU0607220059.USD","BK1109","LU1328615791.USD","LU0345775950.USD","LU0784639295.USD","SGXZ99366536.SGD","LU0594300179.USD","BK1535","LU1242518931.SGD","LU1366334578.USD","LU1282649067.USD","LU2317271919.USD","LU1688375341.USD","LU0708995153.HKD","SG9999002463.SGD","BK1586","BK1529","LU0385154629.USD","LU0516423174.USD","LU0823426480.USD","LU1226287529.USD","LU2476274720.SGD","06100","LU2237443622.USD","SG9999001846.SGD","LU0918141705.HKD","LU0214875030.USD","LU0823426308.USD","LU1196710864.SGD","IE0003795394.USD","BK1226","LU0862451753.SGD","BK1574","LU0540923850.HKD","LU1044874839.SGD","BK1606","LU0173614495.USD","LU0868486357.SGD","BK1209","BK1549","LU2237443549.SGD","TCHmain","LU0359201885.HKD","LU0320764599.SGD","LU0880133367.SGD","SG9999001069.SGD","LU0823413587.USD","LU1642822792.SGD","LU0128522157.USD","LU1303224171.USD","LU2023250504.SGD","BK1523","LU1048596156.SGD","LU1810669033.SGD","BK1612","LU0210527791.USD","SG9999007991.SGD","BK1500","BK1191","LU1880383440.USD","LU0516423091.SGD","LU0633140727.USD","BK1132","IE0008368411.USD","06608","LU0287142896.SGD","LU1974910355.USD","LU0315178854.USD","LU0823039010.USD","IE00BZ08YR35.GBP","BK1590","BK1229","BK1222","LU0348767384.USD","LU0642271901.SGD","LU1515016050.SGD","LU0235996351.USD","IE0001KFT4U8.USD","LU0516422440.USD","LU0633140560.USD","LU0417516571.SGD","SG9999015978.USD","LU0315179316.USD","LU0096374516.USD","IE0032834883.USD","LU0828238088.HKD","SG9999014906.USD","BK1618","LU0163747925.USD","LU2237443978.SGD","LU0067412154.USD","LU1188198961.HKD","LU2152927971.USD","BK1539","LU2226246903.HKD","SG9999006514.SGD","01995","LU0791591158.USD","LU0499858602.USD","IE00B29SXG58.USD","LU0320764243.SGD","BK1518","LU0737861699.HKD","LU0348825331.USD","SG9999002562.SGD","LU1804176565.USD","LU0264606111.USD","LU0254981946.USD","01066","LU0348827113.USD","LU0572944931.SGD","LU0188438112.USD","LU0456842615.SGD","LU0143863784.USD","SG9999014880.SGD","LU0052750758.USD","LU0328353924.USD","LU0588545904.SGD","LU0228659784.USD","LU1880383366.USD","00700","BK1553","LU0708995583.HKD","LU0307460666.USD","LU1051769294.HKD","HK0000320264.USD","LU2125910500.SGD","LU2462611646.USD","LU2498475776.HKD","LU1719994722.HKD","06868","LU0572939691.SGD","BK1131","BK1189","LU0345769631.USD","IE00BQXX3D17.EUR","LU1102505762.USD","LU1051768304.USD","00383","LU1861219969.SGD","LU0985320562.USD","LU0589944569.HKD","IE00B031HW06.USD","LU1196710351.USD","LU1813983027.USD","IE00B543WZ88.USD","IE00BYTNYN87.SGD","LU0918141887.USD","IE00B97KM107.HKD","LU0873338254.USD","LU2449936058.SGD","LU0898667661.SGD","LU2237443465.HKD","SG9999017495.SGD","LU0169518387.USD","LU0048580855.USD","GELYY","BK1124","IE00BPRC5H50.USD","01773","IE00B12V2V27.USD","BK1247","LU1831875114.USD","SG9999004311.SGD","LU0181495838.USD","LU0359201612.USD","LU0819123356.HKD","LU2257852520.SGD","SG9999006597.SGD","HTCD.SI","BK1207","LU0047713382.USD","LU1048588211.SGD","SG9999001903.USD","LU0348816934.USD","LU1048484197.HKD","LU2125910849.SGD","LU1961090484.USD","BK1593","LU0823041008.USD","SG9999014674.SGD","LU2237443382.USD","01681","LU2362541513.USD","LU1733274390.USD","LU0348805143.USD","LU0672654166.SGD","01651","LU0080751232.USD","IE00B3M56506.USD","00386","LU1861214812.USD","LU2265009873.SGD","SGXZ31699556.SGD","LU0455707207.USD","LU0871576103.HKD"],"gpt_icon":1},{"id":"1118205039","title":"CARSGEN-B Spent HK$6.737 Million to Repurchase 466,000 Shares on December 17","url":"https://stock-news.laohu8.com/highlight/detail?id=1118205039","media":"Deep News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1118205039?lang=en_us&edition=fundamental","pubTime":"2025-12-18 08:41","pubTimestamp":1766018472,"startTime":"0","endTime":"0","summary":"CARSGEN-B (02171) announced that on December 17, 2025, the company repurchased 466,000 shares at a total cost of HK$6.737 million.","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","BK1587","BK1585","02171","BK1161"],"gpt_icon":0},{"id":"1108309207","title":"BIOSTAR PHARM-B (02563): First Patient Dosed in U.S. Pivotal Clinical Study of Utidelone for Breast Cancer Brain Metastasis","url":"https://stock-news.laohu8.com/highlight/detail?id=1108309207","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1108309207?lang=en_us&edition=fundamental","pubTime":"2025-12-17 21:37","pubTimestamp":1765978642,"startTime":"0","endTime":"0","summary":"BIOSTAR PHARM-B (02563) announced that its wholly-owned U.S. subsidiary, Biostar Pharma, Inc. (US-Biostar), has completed the first patient dosing in a key overseas clinical study: the U.S. pivotal...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09939","BK1515","BK1574","02563","159938","BK1161"],"gpt_icon":0},{"id":"2592990948","title":"Ascentage Pharma to Present at J.P. Morgan Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2592990948","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592990948?lang=en_us&edition=fundamental","pubTime":"2025-12-17 21:01","pubTimestamp":1765976500,"startTime":"0","endTime":"0","summary":"Ascentage Pharma Group International will present at the 44th Annual J.P. Morgan Healthcare Conference in San Francisco, CA. The company's presentation is scheduled for Wednesday, January 14, 2026, at 2:15 p.m. PT.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Ascentage Pharma Group International published the original content used to generate this news brief via GlobeNewswire  on December 17, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251217:nNDL3kLYZQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0314104364.USD","LU2210149790.SGD","BK1161","06855","IE00BGHQF748.EUR","NDAQ","BK4588","SG9999014005.SGD","BK4585","IE00B3QW5Z07.USD","SG9999014021.USD","SG9999014013.SGD","LU2095319765.USD","IE00BKPKM429.USD","IE00B64PRP62.GBP","SG9999014039.USD","LU2210150020.SGD","BK1574","BK4112"],"gpt_icon":0},{"id":"1198743414","title":"AH Healthcare Assets Stage Afternoon Reversal! Medical ETF Forms Bullish Engulfing Pattern at Low, Signaling Trend Shift? Heavy \"Bottom-Fishing\" in HK Connect Innovative Pharma, 520880 Hits Record High","url":"https://stock-news.laohu8.com/highlight/detail?id=1198743414","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1198743414?lang=en_us&edition=fundamental","pubTime":"2025-12-17 20:01","pubTimestamp":1765972884,"startTime":"0","endTime":"0","summary":"On December 17, A-shares and Hong Kong stocks staged a coordinated afternoon rebound, with the Shanghai Composite rising 1.19% and the Hang Seng Index gaining 0.92%. A+H healthcare assets followed...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","09939","BK1574","512170","BK1515","159828","159938","520880","06978","159992"],"gpt_icon":0},{"id":"2592991610","title":"Alphamab Oncology's Application for Tumor Drug Accepted by Chinese Regulator","url":"https://stock-news.laohu8.com/highlight/detail?id=2592991610","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592991610?lang=en_us&edition=fundamental","pubTime":"2025-12-17 19:11","pubTimestamp":1765969904,"startTime":"0","endTime":"0","summary":"Alphamab Oncology's  investigational new drug application for JSKN027 was accepted by China's National Medical Products Administration, a Wednesday Hong Kong bourse filing said.The firm plans to initiate a phase I clinical study of JSKN027 for the treatment of advanced malignant solid tumors to evaluate its safety, tolerability, pharmacokinetics, pharmacodynamics, and preliminary anti-tumor activity.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK1161","BK1574","09966"],"gpt_icon":0},{"id":"1186071414","title":"ALPHAMAB-B (09966): JSKN027 IND Application Officially Accepted by CDE","url":"https://stock-news.laohu8.com/highlight/detail?id=1186071414","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1186071414?lang=en_us&edition=fundamental","pubTime":"2025-12-17 18:18","pubTimestamp":1765966713,"startTime":"0","endTime":"0","summary":"ALPHAMAB-B (09966) announced that the Investigational New Drug (IND) application for its self-developed PD-L1/VEGFR2 bispecific antibody-drug conjugate (ADC) JSKN027 has been officially accepted by...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","CDE","LU1223082519.USD","09966","LU1223083913.SGD","IND","BK4017","BK1161","LU1223082196.USD"],"gpt_icon":0},{"id":"2592996320","title":"Alphamab Oncology IND Application for JSKN027 Accepted by Chinese Regulator","url":"https://stock-news.laohu8.com/highlight/detail?id=2592996320","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592996320?lang=en_us&edition=fundamental","pubTime":"2025-12-17 18:04","pubTimestamp":1765965861,"startTime":"0","endTime":"0","summary":"Alphamab Oncology announced that its Investigational New Drug  application for JSKN027, an independently developed PD-L1/VEGFR2 bispecific antibody-drug conjugate, has been officially accepted by the Center for Drug Evaluation  of the National Medical Products Administration of China. The company plans to initiate a phase I clinical study to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics, and preliminary anti-tumor activity of JSKN027 in patients with advanced malignant solid tumors.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Alphamab Oncology published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange  , on December 17, 2025","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251217:nNDLzsP3M:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","09966","BK1161"],"gpt_icon":0}],"pageSize":20,"totalPage":15,"pageCount":1,"totalSize":298,"code":"91000000","status":"200"}]}}